Benztropine Mesylate Tablet
FDA Label NDC 0904-7288

19 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Benztropine Mesylate (NDC 0904-7288). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, indications and usage, contraindications, warnings, general, drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7288-61

Unit Dose

Benztropine

Mesylate

Tablets, USP

0.5 mg

100 TABLETS (10 x 10)

Rx only

0.5mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 02)

0.5mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 02)

MAJOR®

NDC 0904-7289-61

Unit Dose

Benztropine

Mesylate

Tablets, USP

1 mg

100 TABLETS (10 x 10)

Rx only

1mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 01)

1mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 01)

MAJOR®

NDC 0904-7290-61

Unit Dose

Benztropine

Mesylate

Tablets, USP

2 mg

100 TABLETS (10 x 10)

Rx only

2mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 00)

2mg Carton Label (F572eba2 Cce7 4e65 9df4 9c0585530c0b 00)

* Please review the disclaimer below.